Jam

Macy’s, Inc. announced early results of its cash tender offer, increasing the maximum amount to $250 million. The offer targets outstanding notes and debentures, prioritizing retirement based on a predetermined hierarchy. Early tenders exceeded the initial target, and Macy’s will accept specific amounts of each series. The Early Settlement Date is set for July 29, 2025. The company plans to use proceeds from a new senior notes offering and existing cash to fund the buyback, redeem other debt, and cover related expenses.

Ardagh Group S.A. has announced a comprehensive recapitalization agreement with key financial players, including its controlling shareholder and a significant creditor coalition. The deal slashes $4.3 billion in debt via a debt-for-equity swap, extends bond maturities to 2030, and injects $1.5 billion in new capital. Ownership will transfer to noteholders, while Ardagh retains its Glass and Metal Packaging businesses. The transaction, expected to close by September 30, 2025, is subject to regulatory approvals.

Truecaller (TRUBF) continues its share repurchase program, buying back 145,000 B shares in week 30, 2025, at an average price of 53.19 SEK. Since May 30, 2025, they’ve reacquired 400,000 shares (0.11% of outstanding capital). The program, authorized until the 2026 AGM, allows repurchasing up to 10% of outstanding shares. Truecaller now holds 4,345,332 B shares and 5,013,786 C-shares, representing 2.65% of outstanding capital, leaving 344,390,935 shares outstanding.

Faraday Future (FFAI) celebrated its 4th public listing anniversary with a business update from Founder YT Jia, highlighting over 10,000 paid pre-orders for the FX Super One MPV. Jia emphasized the Super One’s innovative features, including its “First Class EAI-MPV” category, AI capabilities, and focus on safety and luxury. The company showcased the FX Super One and FF 91 on Capitol Hill, advocating for American manufacturing and innovation. Faraday Future is also exploring Web3 applications and will present the FX Super One at Pebble Beach.

Hengrui Pharma and GSK will co-develop up to 12 innovative medicines in a strategic partnership. GSK gains an exclusive license (excluding specific regions of China) for HRS-9821, a potential best-in-class PDE3/4 inhibitor for COPD, adding to their respiratory portfolio. Hengrui will advance 11 additional programs through Phase I, after which GSK can license them, paying $500M upfront. Hengrui could receive up to $12B in milestone payments and tiered royalties.

Tamboran Resources Corporation announced Dick Stoneburner as interim CEO, succeeding Joel Riddle, and the appointment of Scott Sheffield and Phillip Pace as Non-Executive Directors, replacing John Bell Sr. These changes maintain a nine-member board. Sheffield and Pace bring extensive energy expertise. The company entered an agreement with Sheffield Holdings, its major stockholder. Tamboran reaffirms its commitment to the Beetaloo Basin development and thanked Riddle and Bell for their service.

KKR will invest A$500 million in CleanPeak Energy, marking KKR’s first Asia-Pacific investment under its Global Climate Transition strategy. The partnership aims to expand CleanPeak’s distributed energy platform, focusing on solar, battery storage, and microgrids for commercial and industrial sectors in Australia. CleanPeak, a specialist in renewable energy, provides integrated solar-and-storage systems to blue-chip companies. The investment is expected to be finalized in the latter half of 2025, pending regulatory approvals.

Precision Global Corporation (PGC) has partnered with CubeSmart to manage four self-storage facilities in Texas, effective July 25, 2025. The agreement leverages CubeSmart’s operational expertise to enhance customer experience and asset value. PGC aims to expand its nationwide portfolio of storage and RV park assets through strategic alliances. CubeSmart, a leading self-storage REIT, manages over 1,300 facilities nationwide, known for its technology-driven solutions and customer-centric approach. PGC focuses on high-growth, income-producing assets and seeks acquisition opportunities to expand its portfolio.

Hawaii American Water customers in Hawaii Kai, Mauna Lani, and Waimea will see wastewater bill adjustments starting in August 2025, following HPUC approval. The rate hike is driven by a $40 million infrastructure investment. Hawaii Kai residents will see a $4 monthly increase, while Mauna Lani and Waimea residents will see an $18-$25 increase. The upgrades aim to maintain service quality, meet environmental regulations, and improve treatment facilities. American Water, the parent company, is the largest regulated water and wastewater utility in the US.

Assembly Biosciences (ASMB) announced promising Phase 1a data for HSV treatments, ABI-5366 and ABI-1179, at recent conferences. These helicase-primase inhibitors demonstrated favorable safety and pharmacokinetics in healthy volunteers, potentially allowing for less frequent dosing: once-weekly for both and potentially once-monthly for ABI-5366. No significant food effect was observed. Phase 1b trials are underway, with interim data expected in fall 2025, a possible inflection point for Assembly Biosciences.